Clinical predictors of physiologic change after treatment with immunosuppression in hypersensitivity pneumonitis
Our study demonstrates that certain radiographic variables trend toward a significant impact on FVC% predicted as well as DLCO% predicted and suggests that antifibrotic therapy may be a better initial choice of therapy in patients with fibrotic hypersensitivity pneumonitis as decline occurred with or without the use of immunosuppression.
Authors
- Craig S. Glazer
- J. Liu (ORCID: https://orcid.org/0009-0006-4638-3838)
- Traci N. Adams (ORCID: https://orcid.org/0000-0002-5834-459X)
- Esther de Boer
- Margaret Kypreos (ORCID: https://orcid.org/0000-0002-6781-2199)
- Graham Reed Ellington
- Genichiro Fujioka
Institutions
- Pulmonary Associates (US)
- The University of Texas Southwestern Medical Center (US)
- Texas A&M University (US)
- Bryan College (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1371/journal.pone.0313540
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00